NO142024C - Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus - Google Patents

Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus

Info

Publication number
NO142024C
NO142024C NO743758A NO743758A NO142024C NO 142024 C NO142024 C NO 142024C NO 743758 A NO743758 A NO 743758A NO 743758 A NO743758 A NO 743758A NO 142024 C NO142024 C NO 142024C
Authority
NO
Norway
Prior art keywords
vaccine
virus
culture
procedure
preparation
Prior art date
Application number
NO743758A
Other languages
English (en)
Other versions
NO743758L (no
NO142024B (no
Inventor
Ian George Furminger
Margaret Irene Brady
Original Assignee
Flockhart & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flockhart & Co filed Critical Flockhart & Co
Publication of NO743758L publication Critical patent/NO743758L/no
Publication of NO142024B publication Critical patent/NO142024B/no
Publication of NO142024C publication Critical patent/NO142024C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO743758A 1973-10-18 1974-10-17 Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus NO142024C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48685/73A GB1486557A (en) 1973-10-18 1973-10-18 Process for the preparation of pyrogen-free sub-unit vaccine

Publications (3)

Publication Number Publication Date
NO743758L NO743758L (no) 1975-05-12
NO142024B NO142024B (no) 1980-03-10
NO142024C true NO142024C (no) 1980-06-18

Family

ID=10449549

Family Applications (1)

Application Number Title Priority Date Filing Date
NO743758A NO142024C (no) 1973-10-18 1974-10-17 Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus

Country Status (15)

Country Link
JP (1) JPS5082228A (no)
AT (1) AT334524B (no)
BE (1) BE821175A (no)
CA (1) CA1050886A (no)
CH (1) CH611518A5 (no)
DE (1) DE2449530C2 (no)
DK (1) DK138581B (no)
FR (1) FR2248054B1 (no)
GB (1) GB1486557A (no)
IE (1) IE40187B1 (no)
IL (1) IL45870A (no)
NL (1) NL181553C (no)
NO (1) NO142024C (no)
SE (1) SE426439B (no)
ZA (1) ZA746398B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK276380A (da) * 1979-07-09 1981-01-10 Univ Iowa State Res Found Inc Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CA2423610A1 (en) * 2000-10-02 2002-04-11 Glaxosmithkline Biologicals S.A. Split enveloped virus preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
CH611518A5 (en) 1979-06-15
DK138581B (da) 1978-10-02
IL45870A (en) 1978-03-10
IE40187B1 (en) 1979-03-28
DE2449530A1 (de) 1975-04-30
ATA835074A (de) 1976-05-15
DE2449530C2 (de) 1985-08-08
DK543974A (no) 1975-06-16
NL7413642A (nl) 1975-04-22
IL45870A0 (en) 1974-12-31
NO743758L (no) 1975-05-12
NO142024B (no) 1980-03-10
NL181553C (nl) 1987-09-16
FR2248054A1 (no) 1975-05-16
NL181553B (nl) 1987-04-16
SE7413113L (no) 1975-04-21
ZA746398B (en) 1976-06-30
GB1486557A (en) 1977-09-21
AU7444974A (en) 1976-04-29
JPS5082228A (no) 1975-07-03
BE821175A (fr) 1975-04-17
IE40187L (en) 1975-04-18
DK138581C (no) 1979-03-12
FR2248054B1 (no) 1978-07-28
AT334524B (de) 1976-01-25
SE426439B (sv) 1983-01-24
CA1050886A (en) 1979-03-20

Similar Documents

Publication Publication Date Title
NO143940C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere
OA04704A (fr) Procédé de préparation de nouveaux vaccins.
RO69182A (ro) Procedeu pentru prepararea unor aciloxi-aldehide
RO69607A (ro) Procedeu pentru prepararea unor 3-carbamoiloximetilcefalosporine
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
NO740670L (no) Analogifremgangsmåte for fremstilling av nye 1-aryloksy-2-hydroksy-3-alkynylaminopropanforbindelser.
DK143437C (da) Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus
NO142024C (no) Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus
SE387341B (sv) Forfarande for framstellning av 1-aryl-n-dialkyl-aminoalkyl-3,4-dihydro2(h)-isokinolinkarboxamider
SE397201B (sv) Forfarande for framstellning av glukosisomeras fran en mikroorganism av slektet actionoplanes
DK131633B (da) Fremgangsmåde til fremstilling af 3-(17beta-4-androsten-3-on-17beta-yl)-propiolacton.
RO69264A (ro) Procedeu pentru prepararea alfa-amino-alcoolilor
NO741133L (no) Fremgangsmåte for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-N1.N4-dioksyd.
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
CH611338A5 (en) Process for the preparation of inactivated HB-Ag vaccines
RO72838A (ro) Procedeu de preparare a 3-(2-fluor-4-bifenilil)-1-butanol
DK136602B (da) Fremgangsmåde til fremstilling af farvet mangan-ethylen-bis-dithiocarbamat (maneb).
NO741141L (no) Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive benzopyranopyridinderivater.
RO65994A (ro) Procedeu pentru prepararea unor diaminobenzofenone
NO140297C (no) Fremgangsmaate ved fremstilling av alfa1-t-butylaminomethyl-4-hydroxy-m-xylen-alfa1,alfa3-diol
SE396212B (sv) Forfarande for framstellning av ett alkalimetallditionit
NO740744L (no) Fremgangsmåte til fremstilling av oksiranforbindelser.
NO740229L (no) Fremgangsmåte ved fremstilling av 4-acetamidofenyl-2-acetoxybenzoat.
NO744259L (no) Fremgangsmåte ved fremstilling av 1alfa,3beta-dihydroksy-steroid-5-en eller et 1alfa-beskyttet hydroksyl-derivat derav.